Tirzepatide injections

Tirzepatide is a novel injectable medication designed for managing type 2 diabetes, offering dual action as a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist. Administered weekly, it improves glycemic control by mimicking insulin response and suppressing appetite, aiding in weight management. Clinical trials show effectiveness in lowering blood glucose levels and significant weight loss, marking it a promising option in diabetes care. However, potential side effects necessitate careful evaluation by healthcare providers for patient suitability.

Select Wishlist

Cart Menu Button Image8Left Menu Icon
Your Cart